politics

What We Know About RFK Jr.'s Vaccine Advisory Panel Overhaul

News

· politics, science

A healthcare worker preparing a vaccine syringe at a clinic counter
Photo by Thirdman / Pexels · source

New vaccines approved by federal regulators have no path to insurance coverage right now because the government panel that issues coverage recommendations has no new members and no scheduled meetings, according to The Guardian. The result, one patient told the paper, is "a mess right now."

What did RFK Jr. change about vaccine policy?

Health and Human Services Secretary Robert F. Kennedy Jr. cut childhood immunization recommendations by a third and replaced members of the Advisory Committee on Immunization Practices (ACIP) with his own picks, The Guardian reports. ACIP is the federal body whose recommendations determine which vaccines insurers must cover without cost-sharing. By removing sitting experts and installing allies, Kennedy altered the composition of the panel that effectively controls whether a new vaccine reaches patients at no out-of-pocket cost.

Why did a judge halt the ACIP overhaul?

A judge's order halted Kennedy's changes to the committee because they were not carried out correctly, according to the Guardian report. The ruling froze the restructuring in place rather than reversing it outright. Kennedy has not nominated replacement members since the order, the outlet reports, leaving the committee without the people needed to issue any new recommendations — even as the court order theoretically allows the process to restart.

Why are new vaccines like the Moderna flu shot in limbo?

The practical effect is that vaccines the Food and Drug Administration has already approved are stuck waiting for ACIP action that is not coming. The Guardian's reporting centers on Ron Kroening, 63, whose doctor recommended the new Moderna mRNA flu vaccine after the FDA approved it in August for people 50 and older. Trials cited in the Guardian report suggest the shot offers stronger protection than traditional flu vaccines. Kroening had to search for the one pharmacy in his area that stocked it. Experts quoted by the outlet say it is likely ACIP will not recommend the shot by the end of the year, which matters because insurance coverage requirements are tied directly to ACIP's recommendation list, not FDA approval alone.

How does this affect what patients pay?

Without an ACIP recommendation, insurers are not required to cover a vaccine, which is what happened to Kroening. He was charged a $40 co-pay for a flu shot — something he said he had never paid for before. He told the Guardian his insurer explained the charge directly: "The reason the mRNA isn't covered is because it's not listed as an ACIP vaccine." The Guardian reports that if the committee does not recommend the shot by year's end, insurers will not be required to cover it until January 2029 at the earliest — a gap of more than two years for a vaccine the FDA has already cleared as safe and effective.

When could ACIP start issuing new recommendations again?

The timeline is uncertain because it depends on steps that have not happened yet. The court order addressed how Kennedy restructured the committee, not when new members must be seated. Kennedy has not put forward nominees, the Guardian reports, so there is no scheduled process by which ACIP would take up the Moderna flu vaccine or any other newly approved shot. Until nominations are made, vetted and the committee reconvenes, the backlog of unreviewed vaccines will keep growing alongside new FDA approvals.

What happens next for vaccine coverage?

The immediate question is whether HHS moves to nominate new ACIP members before more vaccines clear the FDA without a path to coverage. Barring that, patients like Kroening are left to either pay out of pocket, as he did, or go without newer vaccine options that their own doctors are recommending. The Guardian's reporting does not indicate a public timeline from HHS for naming replacement committee members, and the outlet notes the uncertainty could persist for years given the January 2029 coverage threshold tied to the current recommendation cycle. For now, the structural question — who sits on ACIP, and when they will meet — remains unresolved, even as the FDA continues to approve new shots that the insurance system has no mechanism to cover.

The original reporting, including additional detail on Kroening's case and the court order, is available from The Guardian.

Quotags is A quote-card app first shipped in 2013. Version 2.0 is returning soon — do not install an old binary.

Disclosure. This article may include affiliate links; we may earn a commission at no extra cost to you. Legal entity: Pinewood Creations LLC. Smorgi Apps appears only as an affiliate partner in house slots — not as publisher or owner. See our affiliate disclosure.

Questions

Why isn't the new Moderna flu vaccine covered by insurance?

Insurers are only required to cover vaccines once the Advisory Committee on Immunization Practices (ACIP) formally recommends them, and ACIP has not acted on the FDA-approved Moderna mRNA flu shot, according to The Guardian.

Why hasn't ACIP issued new vaccine recommendations?

A judge halted Secretary Robert F. Kennedy Jr.'s restructuring of the committee for being done improperly, but Kennedy has not nominated new members since, leaving the panel unable to meet or vote, The Guardian reports.

When might insurers be required to cover newly approved vaccines?

If ACIP does not recommend a vaccine by the end of 2026, coverage requirements may not take effect until January 2029 at the earliest, per the Guardian's reporting.

Sources

More from HTT News

Briefing

Top stories from the HTT News network by email. Free. No noise.